Intranasal delivery of chitosan-coated bilosomes for repurposing Olmesartan in Alzheimer’s disease therapy: Formulation, optimization, pharmacokinetic and pharmacodynamic evaluation
- 7 March 2026
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 115 (5) , 104241
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Repurposing drugs: promising therapeutic approach against Alzheimer’s diseaseAgeing Research Reviews, 2025
- The Enterococcus secretome inhibits the growth of vancomycin-resistant Enterococcus faecalis V853 with their antiproliferative properties and nanoencapsulation effectsInternational Microbiology, 2024
- Alzheimer’s disease: Insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugsBiochemical Pharmacology, 2023
- Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer’s disease: Past, present and futureAgeing Research Reviews, 2022
- A novel nanogel loaded with chitosan decorated bilosomes for transdermal delivery of terbutaline sulfate: artificial neural network optimization, in vitro characterization and in vivo evaluationDrug Delivery and Translational Research, 2019
- Evaluation and optimization of pH-responsive niosomes as a carrier for efficient treatment of breast cancerDrug Delivery and Translational Research, 2018
- Quercetin-Loaded Lecithin/Chitosan Nanoparticles for Functional Food ApplicationsFood and Bioprocess Technology, 2013
- Protective Effects of Angiotensin II Type-1 Receptor Blockade With Olmesartan on Spinal Cord Ischemia-Reperfusion Injury: An Experimental Study on RatsAnnals of Vascular Surgery, 2010
- Modified Ellman procedure for assay of cholinesterases in crude enzymatic preparationsAnalytical Biochemistry, 1978
- Determination of malonaldehyde precursor in tissues by thiobarbituric acid testAnalytical Biochemistry, 1978